- Research
Landmark Canadian-led trial finds many atrial fibrillation patients can stop taking blood thinners
A new trial co-led by the Ottawa Heart Institute and the Research Institute of the McGill University Health Centre shows that continuing these medications offers no added protection against stroke or embolic events compared with low-dose aspirin
Hearts and minds unite in Quebec City for Canada’s premier cardiovascular congress
Highlights from the congress floor!
- Research
Heart Institute scientist advises on national report on research security and open science
Report explores how Canada can protect sensitive research while continuing to support innovation and open science
The whiteboard changing patient care: A simple fix with a big impact
Even the simplest tools can be transformed to improve care
- Research
Heart Institute researchers to advance studies in grief, heart remodelling, genetics and inflammation
The Grant-in-Aid Program provides operating support for important, innovative research in heart disease and stroke
- Research
Heart Institute joins research partnership to advance AI in heart care
The collaboration aims to develop and validate AI tools that support clinicians in making more informed decisions, leading to better outcomes for patients
Healing beyond the hospital: Inuit cardiac care rooted in culture and connection
The Ottawa Heart Institute and Larga Baffin are reshaping how culturally respectful, accessible care is offered to Inuit patients, helping them heal in body, heart and spirit.
New study shows nicotine pouches may reduce smoking but do not help people quit
Heart Institute researchers have completed the first major review of studies looking at how tobacco-free nicotine pouches affect smoking habits
Ottawa Heart Institute to screen one million Canadians for heart disease as part of new five-year strategic plan
New plan prioritizes prevention, timely access, and innovation to address the world’s leading cause of death